Bruker Corpの収益品質スコアはB+/47.977127です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Bruker Corpはいつ収益を報告しますか?
Bruker Corpの次の収益報告は2026-08-04に予定されています
Bruker Corpの予想収益はいくらですか?
ウォール街のアナリストによると、Bruker Corpの予想収益は$812.27Mです。
Bruker Corpは収益予想を上回りましたか?
Bruker Corpの最近の収益は$823.4Mで、予想をビート。
主要データ
前終値
$52.47
始値
$51.38
当日レンジ
$50.78 - $51.87
52週レンジ
$28.53 - $64.54
取引高
1.8M
平均取引高
2.3M
配当利回り
0.53%
1株当たり利益(TTM)
-0.08
時価総額
$7.8B
BRKRとは何ですか?
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. The firm's segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). Its BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research and development solutions in chemical research fields. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and others.